Feb 4 • 08:49 UTC 🇩🇰 Denmark Politiken

Novo-chef: We are affected by two factors that pull in the wrong direction

Novo Nordisk anticipates a revenue decline of 5 to 13 percent in 2026 due to two specific factors, despite not expecting a drop in demand for its medications.

📡 Similar Coverage